Acasă › Cancer pulmonar › Illinois › Joliet
Studii clinice pentru Cancer pulmonar în Joliet, IL
12 studii pentru Cancer pulmonar caută participanți în și în jurul orașului Joliet (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · La 6 mi distanță
- University of Chicago Medicine-Orland Park, Orland Park · La 14 mi distanță
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
În curs de recrutareFaza 3
- Northwestern Medicine Orland Park, Orland Park · La 14 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Northwestern Medicine Orland Park, Orland Park · La 14 mi distanță
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
În curs de recrutareFaza 2
- Hope and Healing Clinical Research, New Lenox · La 6 mi distanță
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Hope and Healing Cancer Services, New Lenox · La 6 mi distanță
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
În curs de recrutareFaza 2
- Hope and Healing Clinical Research, New Lenox · La 6 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Hope and Healing Cancer Services, New Lenox · La 6 mi distanță
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
În curs de recrutareFaza 1/2
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · La 6 mi distanță
- University of Chicago Medicine-Orland Park, Orland Park · La 14 mi distanță
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- University of Chicago, New Lenox · La 6 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Orland Park, Orland Park · La 14 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Orland Park, Orland Park · La 14 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Northwestern Medicine Orland Park, Orland Park · La 14 mi distanță
Studii pentru Cancer pulmonar în alte orașe
- Houston, TX78 studii
- Boston, MA62 studii
- New York City, NY60 studii
- Los Angeles, CA45 studii
- Washington, DC41 studii
- Arlington, VA41 studii
- Chicago, IL41 studii
- Nashville, TN40 studii
- Baltimore, MD40 studii
- St. Louis, MO39 studii
- Columbus, OH37 studii
- Philadelphia, PA36 studii
Alte studii în Joliet
- Cancer pulmonar cu celule non-pătrate12 studii
- Cancer metastatic7 studii
- Cancer de vezică urinară7 studii
- Carcinom cu celule scuamoase de cap și gât6 studii
- Cancer de prostată5 studii
- Cancer hipofaringian5 studii
- Cancer laringian5 studii
- Cancer oral5 studii
- Leucemie mieloasă acută5 studii
- Cancer de sân4 studii
- Cancer de colon4 studii
- Cancer renal (carcinom cu celule renale)4 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.